Horizant 300 mg/1
gabapentin enacarbil · TABLET, EXTENDED RELEASE · Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)
Horizant is a tablet, extended release containing gabapentin enacarbil at 300 mg/1, taken oral. Manufactured by Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals).
Key Facts
- Brand Name
- Horizant
- Generic Name
- gabapentin enacarbil
- NDC Code (Product)
53451-0103- Manufacturer
- Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)
- Strength
- 300 mg/1
- Dosage Form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing Status
- Application #
- NDA022399
- Marketing Start
- 05/01/2013
Recall History
No Recall HistoryFrequently Asked Questions
What is Horizant used for?
Horizant contains gabapentin enacarbil. It is a tablet, extended release taken oral. Consult your doctor for specific uses.
Is Horizant a controlled substance?
Horizant is not classified as a controlled substance by the DEA.
What is the generic name for Horizant?
The generic name for Horizant is gabapentin enacarbil. There are no other listed brand versions of gabapentin enacarbil.
What is the NDC code for Horizant 300 mg/1?
The NDC (National Drug Code) for Horizant 300 mg/1 is 53451-0103, listed by Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals).
Other Horizant Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)